Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats

Drug and Alcohol Dependence

Volumn 116, Issue 1-3, 2011, Pages 72-79

  Figueroa Guzman, Yazmin ^a   Mueller, Christopher ^a   Vranjkovic, Oliver ^a   Wisniewski, Samantha ^a   Yang, Zheng ^c   Li, Shi Jiang ^b   Bohr, Colin ^a   Graf, Evan N ^a   Baker, David A ^a   Mantsch, John R ^a  

^a MARQUETTE UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Cocaine; Craving; Dopamine; Reinstatement; Relapse; THP

Indexed keywords

COCAINE; TETRAHYDROPALMATINE;

ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; FOOTSHOCK; MALE; MOTOR DYSFUNCTION; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; RAT; REINFORCEMENT; STEPHANIA; STEPHANIA DELAVAYI; STRESS;

ADMINISTRATION, ORAL; ANIMALS; BEHAVIOR, ADDICTIVE; BERBERINE ALKALOIDS; COCAINE; COCAINE-RELATED DISORDERS; CUES; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PHYTOTHERAPY; PLANT PREPARATIONS; PLANT ROOTS; RATS; RATS, SPRAGUE-DAWLEY; RECURRENCE; SELF ADMINISTRATION; STEPHANIA; STRESS, PHYSIOLOGICAL;

RATTUS;

EID: 79957593608     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.11.023     Document Type: Article

References (78)

1. Ahmed S.H., Koob G.F. Cocaine- but not food-seeking behavior is reinstated by stress after extinction. Psychopharmacology 1997, 132:289-295.
2. Alleweireldt A.T., Weber S.M., Kirschner K.F., Bullock B.L., Neisewander J.L. Blockade or stimulation of D1 dopamine receptors attenuates cue reinstatement of extinguished cocaine-seeking behavior in rats. Psychopharmacology 2002, 159:284-293.
3. Alleweireldt A.T., Hobbs R.J., Taylor A.R., Neisewander J.L. Effects of SCH-23390 infused into the amygdala or adjacent cortex and basal ganglia on cocaine seeking and self-administration in rats. Neuropsychopharmacology 2006, 31:363-374.
4. Anderson S.M., Schmidt H.D., Pierce R.C. Administration of the D2 dopamine receptor antagonist sulpiride into the shell, but not the core, of the nucleus accumbens attenuates cocaine priming-induced reinstatement of drug seeking. Neuropsychopharmacology 2006, 31:1452-1461.
5. Anderson S.M., Bari A.A., Pierce R.C. Administration of the D1-like dopamine receptor antagonist SCH-23390 into the medial nucleus accumbens shell attenuates cocaine priming-induced reinstatement of drug-seeking behavior in rats. Psychopharmacology 2003, 168:132-138.
6. Anderson S.M., Pierce R.C. Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharmacol. Ther. 2005, 106:389-403.
7. Bachtell R.K., Whisler K., Karanian D., Self D.W. Effects of intra-nucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat. Psychopharmacology 2005, 183:41-53.
8. Bongiovanni M., See R.E. A comparison of the effects of different operant training experiences and dietary restriction on the reinstatement of cocaine-seeking in rats. Pharmacol. Biochem. Behav. 2008, 89:227-233.
9. Burmeister J.J., Lungren E.M., Kirschner K.F., Neisewander J.L. Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacology 2004, 29:660-668.
10. Capriles N., Rodaros D., Sorge R.E., Stewart J. A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats. Psychopharmacology 2003, 168:66-74.
11. Cervo L., Carnovali F., Stark J.A., Mennini T. Cocaine-seeking behavior in response to drug-associated stimuli in rats: involvement of D3 and D2 dopamine receptors. Neuropsychopharmacology 2003, 28:1150-1159.
12. Cervo L., Cocco A., Petrella C., Heidbreder C.A. Selective antagonism at dopamine D3 receptors attenuates cocaine-seeking behaviour in the rat. Int. J. Neuropsychopharmacol. 2007, 10:167-181.
13. Chu H., Jin G., Friedman E., Zhen X. Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction. Cell Mol. Neurobiol. 2008, 28:491-499.
14. Ciccocioppo R., Sanna P.P., Weiss F. Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: reversal by D(1) antagonists. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:1976-1981.
15. Crombag H.S., Grimm J.W., Shaham Y. Effect of dopamine receptor antagonists on renewal of cocaine seeking by reexposure to drug-associated contextual cues. Neuropsychopharmacology 2002, 27:1006-1015.
16. De Vries T.J., Schoffelmeer A.N., Binnekade R., Vanderschuren L.J. Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration. Psychopharmacology 1999, 143:254-260.
17. De Vry J., Donselaar I., Van Ree J.M. Food deprivation and acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and haloperidol. J. Pharmacol. Exp. Ther. 1989, 251:735-740.
18. de Wit H., Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 1981, 75:134-143.
19. Di Ciano P., Underwood R.J., Hagan J.J., Everitt B.J. Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology 2003, 28:329-338.
20. Ding G.S. Important Chinese herbal remedies. Clin. Ther. 1987, 9:345-357.
21. Epstein D.H., Preston K.L., Stewart J., Shaham Y. Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology 2006, 189:1-16.
22. Erb S., Shaham Y., Stewart J. Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology 1996, 128:408-412.
23. Ernst E. The efficacy of herbal medicine-an overview. Fundam. Clin. Pharmacol. 2005, 19:405-409.
24. Feltenstein M.W., Altar C.A., See R.E. Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse. Biol. Psychiatry 2007, 61:582-590.
25. Gilbert J.G., Newman A.H., Gardner E.L., Ashby C.R., Heidbreder C.A., Pak A.C., Peng X.Q., Xi Z.X. Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors. Synapse 2005, 57:17-28.
26. Guo X., Wang L.M., Liu J., Jin G.Z. Characteristics of tetrahydroprotoberberines on dopamine D1 and D2 receptors in calf-striatum. Zhongguo Yao Li Xue Bao 1997, 18:225-230.
27. Halbsguth C., Meissner O., Haberlein H. Positive cooperation of protoberberine type 2 alkaloids from Corydalis cava on the GABAA binding site. Planta Med. 2003, 69:305-309.
28. Hong Z., Fan G., Le J., Chai Y., Yin X., Wu Y. Brain pharmacokinetics and tissue distribution of tetrahydropalmatine enantiomers in rats after oral administration. Biopharm. Drug Dispos. 2006, 27:111-117.
29. Horowitz R.S., Feldhaus K., Dart R.C., Stermitz F.R., Beck J.J. The clinical spectrum of Jin Bu Huan toxicity. Arch. Intern. Med. 1996, 156:899-903.
30. Hu J.Y., Jin G.Z. Supraspinal D2 receptor involved in antinociception induced by l-tetrahydropalmatine. Zhongguo Yao Li Xue Bao 1999, 20:715-719.
31. Huang K.X., Jin G.Z. The antagonistic effects of tetrahydroprotoberberines on dopamine receptors: electrophysiological studies. Sci. China B 1992, 35:688-696.
32. Imaki J., Mae Y., Shimizu S., Ohno Y. Therapeutic potential of alpha2 adrenoceptor antagonism for antipsychotic-induced extrapyramidal motor disorders. Neurosci. Lett. 2009, 454:143-147.
33. Jin G.Z., Yu S.X., Yu L.P. Different effects of enantiomers of tetrahydropalmatine on dopaminergic system. Sci. Sin. 1986, 29:1054-1064.
34. Jin G.Z. (-)-Tetrahydropalmatine and its analogues as new dopamine receptor antagonists. Trends Pharmacol. Sci. 1987, 8:81-82.
35. Kalkman H.O., Neumann V., Hoyer D., Tricklebank M.D. The role of alpha2-adrenoceptor antagonism in the anti-cataleptic properties of the atypical neuroleptic agent, clozapine, in the rat. Br. J. Pharmacol. 1998, 124:1550-1556.
36. Khroyan T.V., Barrett-Larimore R.L., Rowlett J.K., Spealman R.D. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J. Pharmacol. Exp. Ther. 2000, 294:680-687.
37. Khroyan T.V., Platt D.M., Rowlett J.K., Spealman R.D. Attenuation of relapse to cocaine seeking by dopamine D1 receptor agonists and antagonists in non-human primates. Psychopharmacology 2003, 168:124-131.
38. Leung W.C., Zheng H., Huen M., Law S.L., Xue H. Anxiolytic-like action of orally administered dl-tetrahydropalmatine in elevated plus-maze. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27:775-779.
39. Liu G.Q., Han B.Y., Wang E.H. Blocking actions of l-stephanine, xylopine and 7 other tetrahydroisoquinoline alkaloids on alpha adrenoceptors. Zhongguo Yao Li Xue Bao 1989, 10:302-306.
40. Liu Y.L., Yan Y.D., Zhou P.L., Wu C.F., Gong Z.H. Levo-tetrahydropalmatine attenuates oxycodone-induced conditioned place preference. Eur. J. Pharmacol. 2009, 602:321-327.
41. Lu Z.Z., Wei X., Jin G.Z., Han Q.D. Antagonistic effects of tetrahydroprotoberberine homologues on alpha-1 adrenoceptor. Yao Xue Xue Bao 1996, 31:652-656.
42. Lu L., Liu Y., Zhu W., Shi J., Liu Y., Ling W., Kosten T.R. Traditional medicine in the treatment of drug addiction. Am. J. Drug Alcohol Abuse 2009, 35:1-11.
43. Madayag A., Kau K.S., Lobner D., Mantsch J.R., Wisniewski S., Baker D.A. Drug-induced plasticity contributing to heightened relapse susceptibility: neurochemical changes and augmented reinstatement in high-intake rats. J. Neurosci. 2010, 30:210-217.
44. Mantsch J.R., Yuferov V., Mathieu-Kia A.M., Ho A., Kreek M.J. Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement and brain mRNA levels in rats. Psychopharmacology 2004, 175:26-36.
45. Mantsch J.R., Li S.J., Risinger R., Awad S., Katz E., Baker D.A., Yang Z. Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats. Psychopharmacology 2007, 192:581-591.
46. Mantsch J.R., Baker D.A., Francis D.M., Katz E.S., Hoks M.A., Serge J.P. Stressor- and corticotropin releasing factor-induced reinstatement and active stress-related behavioral responses are augmented following long-access cocaine self-administration by rats. Psychopharmacology 2008, 195:591-603.
47. Mantsch J.R., Yang Z., Peters C., Valentine A., Becker A., Li S.J., Baker D.A., Wisniewski S. Levo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in rats. Pharmacol. Biochem. Behav. 2010, 97:310-316.
48. Marcenac F., Jin G.Z., Gonon F. Effect of l-tetrahydropalmatine on dopamine release and metabolism in the rat striatum. Psychopharmacology 1986, 89:89-93.
49. McFarland K., Kalivas P.W. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J. Neurosci. 2001, 21:8655-8663.
50. McFarland K., Davidge S.B., Lapish C.C., Kalivas P.W. Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J. Neurosci. 2004, 24:1551-1560.
51. Meil W.M., See R.E. Conditioned cued recovery of responding following prolonged withdrawal from self-administered cocaine in rats: an animal model of relapse. Behav. Pharmacol. 1996, 7:754-763.
52. Millan M.J., Brocco M., Rivet J.M., Audinot V., Newman-Tancredi A., Maiofiss L., Queriaux S., Despaux N., Peglion J.L., Dekeyne A. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors. II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents. J. Pharmacol. Exp. Ther. 2000, 292:54-66.
53. O'Brien C.P. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am. J. Psychiatry 2005, 162:1423-1431.
54. Peng X.Q., Ashby C.R., Spiller K., Li X., Li J., Thomasson N., Millan M.J., Mocaër E., Muńoz C., Gardner E.L., Xi Z.X. The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats. Neuropharmacology 2009, 56:752-760.
55. Platt D.M., Rowlett J.K., Spealman R.D. Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology 2002, 163:265-282.
56. Sanchez C.J., Bailie T.M., Wu W.R., Li N., Sorg B.A. Manipulation of dopamine d1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior. Neuroscience 2003, 119:497-505.
57. Schenk S., Gittings D. Effects of SCH 23390 and eticlopride on cocaine-seeking produced by cocaine and WIN 35,428 in rats. Psychopharmacology 2003, 168:118-123.
58. Schmidt H.D., Pierce R.C. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat. Neuroscience 2006, 142:451-461.
59. Schmidt H.D., Pierce R.C. Systemic administration of a dopamine, but not a serotonin or norepinephrine, transporter inhibitor reinstates cocaine seeking in the rat. Behav. Brain Res. 2006, 175:189-194.
60. Schmidt H.D., Anderson S.M., Pierce R.C. Stimulation of D1-like or D2 dopamine receptors in the shell, but not the core, of the nucleus accumbens reinstates cocaine-seeking behaviour in the rat. Eur. J. Neurosci. 2006, 23:219-228.
61. See R.E., Kruzich P.J., Grimm J.W. Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior. Psychopharmacology 2001, 154:301-310.
62. Sun B.C., Huang K.X., Jin G.Z. Comparison of effects of tetrahydropalmatine enantiomers on firing activity of dopamine neurons in substantia nigra pars compacta. Zhongguo Yao Li Xue Bao 1992, 13:292-297.
63. Sun W., Rebec G.V. The role of prefrontal cortex D1-like and D2-like receptors in cocaine-seeking behavior in rats. Psychopharmacology 2005, 177:315-323.
64. Vocci F.J., Acri J., Elkashef A. Medication development for addictive disorders: the state of the science. Am. J. Psychiatry 2005, 162:1432-1440.
65. Volkow N.D., Fowler J.S., Wang G.J., Swanson J.M. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry 2004, 9:557-569.
66. Vorel S.R., Ashby C.R., Paul M., Liu X., Hayes R., Hagan J.J., Middlemiss D.N., Stemp G., Gardner E.L. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J. Neurosci. 2002, 22:9595-9603.
67. Wadenberg M.L. Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci. Biobehav. Rev. 1996, 20:325-339.
68. Wu G., Jiang J.W., Wu G.C., Cao X.D. Effects of four dopamine agonists on l-tetrahydropalmatine-induced analgesia and electroacupuncture analgesia in rabbits. Zhongguo Yao Li Xue Bao 1990, 11:196-200.
69. Wu J.H., Jin G.Z. Effects of (-) SPD and (-) THP on the firing of noradrenergic neurons in locus coeruleus. Sheng Li Xue Bao 1995, 47:601-604.
70. Xi Z.X., Gilbert J., Campos A.C., Kline N., Ashby C.R., Hagan J.J., Heidbreder C.A., Gardner E.L. Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats. Psychopharmacology 2004, 176:57-65.
71. Xi Z.X., Newman A.H., Gilbert J.G., Pak A.C., Peng X.Q., Ashby C.R., Gitajn L., Gardner E.L. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats. Neuropsychopharmacology 2005, 31:1393-1405.
72. Xi Z.X., Yang Z., Li S.J., Li X., Dillon C., Peng X.Q., Spiller K., Gardner E.L. Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Neuropharmacology 2007, 53:771-782.
73. Xu J., Jin G.Z., Yu L.P., Liu X.J. Differentiation between catalepsies induced by l-tetrahydropalmatine and by haloperidol and morphine. Zhongguo Yao Li Xue Bao 1981, 2:152-155.
74. Xu S.X., Yu L.P., Han Y.R., Chen Y., Jin G.Z. Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain. Zhongguo Yao Li Xuebao 1989, 10:104-110.
75. Yang Z., Shao Y.C., Li S.J., Qi J.L., Zhang M.J., Hao W., et al. Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study. Acta Pharmacol. Sin. 2008, 29:781-788.
76. Yahyavi-Firouz-Abadi N., See R.E. Anti-relapse medications: preclinical models for drug addiction treatment. Pharmacol. Ther. 2009, 124:235-247.
77. Zhang X.Y., Kosten T.A. Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking. Biol. Psychiatry 2005, 57:1202-1204.
78. Zhu X.Z., Zhou Z., Ji X.Q., Gu J., Luo L.G., Wang F.S. l-Tetrahydropalmatine increases leucine enkephalin levels in corpus striatum of rats. Zhongguo Yao Li Xue Bao 1991, 12:104-107.